Known targets — ChEMBL curated mechanism
FAURPL10RPL10ARPL11RPL12RPL13RPL13ARPL14RPL15RPL17RPL18RPL18ARPL19RPL21RPL22RPL23RPL23ARPL24RPL26RPL27RPL27ARPL28RPL29RPL3RPL30RPL31RPL32RPL34RPL35RPL35ARPL36RPL36ARPL37RPL37ARPL38RPL39RPL4RPL41RPL5RPL6RPL7RPL7ARPL8RPL9RPL9P7RPL9P8RPL9P9RPLP0RPLP1RPS10RPS11RPS12RPS13RPS14RPS15RPS15ARPS16RPS17RPS18RPS19RPS2RPS20RPS21RPS23RPS24RPS25RPS26RPS27RPS27ARPS28RPS29RPS3RPS3ARPS4XRPS4Y1RPS5RPS6RPS7RPS8RPS9RPSA
The experimentally established mechanism targets of Cycloheximide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 10/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | NR2F2 | P24468 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | FKBP4 | Q02790 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | SLC2A1 | P11166 | 1/20 | 1.00 |
| ▸ | EIF4A1 | P60842 | 1/20 | 1.00 |
| ▸ | EPAS1 | Q99814 | 1/20 | 1.00 |
| ▸ | FKBP14 | Q9NWM8 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cycloheximide SCHEMBL30020292 | 1.00 | FKBP1A (1.00) | FKBP1ASMN1; SMN2NR2F2ALDH1A1LMNA | |
| Cycloheximide SCHEMBL1714687 | 1.00 | FKBP1A (1.00) | FKBP1ASMN1; SMN2NR2F2ALDH1A1LMNA | |
| Cycloheximide SCHEMBL3764340 | 1.00 | FKBP1A (1.00) | FKBP1ASMN1; SMN2NR2F2ALDH1A1LMNA | |
| Naramycin B SCHEMBL29356383 | 1.00 | FKBP1A (1.00) | FKBP1ASMN1; SMN2NR2F2ALDH1A1LMNA | |
| Cycloheximide SCHEMBL1753509 | 1.00 | FKBP1A (1.00) | FKBP1ASMN1; SMN2NR2F2ALDH1A1LMNA | |
| Cycloheximide SCHEMBL17223570 | 1.00 | FKBP1A (1.00) | FKBP1ASMN1; SMN2NR2F2ALDH1A1LMNA | |
| Cycloheximide SCHEMBL24914327 | 1.00 | FKBP1A (1.00) | FKBP1ASMN1; SMN2NR2F2ALDH1A1LMNA | |
| Cycloheximide SCHEMBL9344504 | 1.00 | FKBP1A (1.00) | FKBP1ASMN1; SMN2NR2F2ALDH1A1LMNA | |
| Cycloheximide SCHEMBL26617 | 1.00 | FKBP1A (1.00) | FKBP1ASMN1; SMN2NR2F2ALDH1A1LMNA | |
| Cycloheximide SCHEMBL3764335 | 1.00 | FKBP1A (1.00) | FKBP1ASMN1; SMN2NR2F2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2833883-A1 | NOVEL COMPOSITIONS OF COMBINATIONS OF NON-COVALENT DNA BINDING AGENTS AND ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS AND THEIR USE IN DISEASE TREATMENT | Indus Pharmaceuticals, Inc. (US) | 2015-02-11 | — | — | EP | claimed |
| WO-2013151638-A1 | NOVEL COMPOSITIONS OF COMBINATIONS OF NON-COVALENT DNA BINDING AGENTS AND ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS AND THEIR USE IN DISEASE TREATMENT | INDUS PHARMACEUTICALS, INC. (US) | 2013-10-10 | — | — | WO | claimed |
| US-20220168278-A1 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | VIRBAC (FR) | 2022-06-02 | — | — | US | disclosed |
| EP-3927341-A1 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | VIRBAC (FR) | 2021-12-29 | — | — | EP | disclosed |
| US-10899932-B2 | Non-amphoteric, quaternisable and water-soluble polymers for modifying the surface charge of solid particles | BASF SE (DE) | 2021-01-26 | — | — | US | disclosed |
| WO-2020201440-A1 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | VIRBAC (FR) | 2020-10-08 | — | — | WO | disclosed |
| US-10759767-B2 | Compositions comprising a triazole compound | BASF Agro B.V. (NL) | 2020-09-01 | — | — | US | disclosed |
| EP-3646731-A1 | PESTICIDAL MIXTURES COMPRISING A PYRAZOLE COMPOUND | BASF SE (DE) | 2020-05-06 | — | — | EP | disclosed |
| EP-3300602-B1 | PESTICIDAL MIXTURES COMPRISING A PYRAZOLE COMPOUND | BASF SE (DE) | 2020-03-25 | — | — | EP | disclosed |
| EP-3498098-A1 | COMPOSITIONS COMPRISING A TRIAZOLE COMPOUND | BASF Agro B.V. (NL) | 2019-06-19 | — | — | EP | disclosed |
| US-20180334569-A9 | NON-AMPHOTERIC, QUATERNISABLE AND WATER-SOLUBLE POLYMERS FOR MODIFYING THE SURFACE CHARGE OF SOLID PARTICLES | BASF SE (DE) | 2018-11-22 | — | — | US | disclosed |
| US-20090042724-A1 | Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-12 | — | — | US | disclosed |
| US-20080293798-A1 | Fungicidal Mixtures Comprising Substituted 1-Methylpyrazol-4-Ylcarboxanilides | BASF AKTIENGELSELLSCHAFT (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080255107-A1 | Fungicidal Mixtures Comprising N-[2-(Haloalk(Enyl)Oxy)Phenyl]Carboxamides | BASF SE (DE) | 2008-10-16 | — | — | US | disclosed |
| US-20080249113-A1 | Fungicidal Mixtures | BASF AKITENGESELLSCHAFT (DE) | 2008-10-09 | — | — | US | disclosed |
| US-20080039319-A1 | Fungicidal Mixtures and Novel Triazolopyrimidines | BASF AKTIENGESELLSCHAFT (DE) | 2008-02-14 | — | — | US | disclosed |
| EP-1813152-A1 | Fungicidal mixture based on 3,4-disubstituted biphenylanilides | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1813151-A1 | Fungicidal compositions based on 1-methyl-pyrazol-4-yl-anilides | BASF Aktiengesellschaft (DE) | 2007-08-01 | — | — | EP | disclosed |
| US-20050227956-A1 | Control of mold growth on wood | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-10-13 | — | — | US | disclosed |
| US-4980346-A | N-ALKYL(ENE)-N-(O,O-DISUBSTITUTED-THIOPHOSPHORYL)-N',N' -SUBSTITUTED GLYCINE AMIDE DERIVATIVES | ESZAKMAGYARORSUAGI VEGYIMUVEK (HU) | 1990-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249113-A1 | Fungicidal Mixtures | ARSA, DDT, AZI2 | FKBP1A 2030/4885SMN1; SMN2 2394/4885NR2F2 1761/4885 |
| US-20220168278-A1 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | P2RX7, CAT, PDE8A | FKBP1A 668/4885SMN1; SMN2 2804/4885NR2F2 3652/4885 |
| US-20080255107-A1 | Fungicidal Mixtures Comprising N-[2-(Haloalk(Enyl)Oxy)Phenyl]Carboxamides | CBR3, CBR1, NAT1 | FKBP1A 2152/4885SMN1; SMN2 3778/4885NR2F2 2563/4885 |
| US-20080293798-A1 | Fungicidal Mixtures Comprising Substituted 1-Methylpyrazol-4-Ylcarboxanilides | CBR3, CBR1, CTRL | FKBP1A 3400/4885SMN1; SMN2 3308/4885NR2F2 2330/4885 |
| US-20090042724-A1 | Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides | CBR3, CBR1, SNU13 | FKBP1A 2735/4885SMN1; SMN2 2440/4885NR2F2 1519/4885 |
| US-20050227956-A1 | Control of mold growth on wood | ERG28, AKR7A2, DPM1 | FKBP1A 2708/4885SMN1; SMN2 1410/4885NR2F2 4124/4885 |
| US-10759767-B2 | Compositions comprising a triazole compound | CYP1B1, CYP3A5, CYP4B1 | FKBP1A 3637/4885SMN1; SMN2 4500/4885NR2F2 2737/4885 |
| US-20080039319-A1 | Fungicidal Mixtures and Novel Triazolopyrimidines | ATIC, ARSA, AOC1 | FKBP1A 1740/4885SMN1; SMN2 2245/4885NR2F2 2112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.